Meeting Overview - The shareholders' meeting of Beijing Hotgen Biotech Co., Ltd. was held on July 4, 2025, at the company's conference room in Daxing Biomedical Industry Base, Beijing [1] - A total of 216 ordinary shareholders attended the meeting, holding 56,565,640 voting rights, which represents 65.7951% of the company's total voting rights [1] Voting Results - All proposed resolutions were approved during the meeting, with the voting results showing overwhelming support from ordinary shareholders [2][3] - The voting breakdown for the resolutions indicated that 99.9571% of the votes were in favor, with only 0.0421% against and 0.0008% abstaining [2] - The resolutions included changes to registration and the election of the fourth board of directors, which also received similar high approval rates [2][3] Legal Compliance - The meeting was conducted in accordance with the Company Law and the Articles of Association, with the presence of legal representatives confirming the legality and validity of the meeting and its resolutions [3]
热景生物: 北京热景生物技术股份有限公司2025年第三次临时股东大会决议